The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

By Menyar Ayman   Altamimi O.   Gomaa Mohamed   Fawzy Zainab   Rahman M.   Bener Abdulbari  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 235-240

Springer Publishing Company

Access to resources Recommend Favorite

Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

By Berger A.K.   Duval S.   Krumholz H.M.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 17-17

Elsevier

Access to resources Recommend Favorite

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995–2002

By Gislason Gunnar   Abildstrom Steen   Rasmussen Jeppe   Rasmussen Søren   Buch Pernille   Gustafsson Ida   Friberg Jens   Gadsbøll Niels   Køber Lars   Stender Steen   Madsen Mette   Torp-Pedersen Christian  

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 1-2, 2005-04 ,pp. : 42-49

Informa Healthcare

Access to resources Recommend Favorite

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relation of Early Changes of QT Dispersion to Changes in Left Ventricular Systolic and Diastolic Function after a First Acute Myocardial Infarction

By Møller Jacob E.   Husic Mirza   Søndergaard Eva   Poulsen Steen H.   Egstrup Kenneth  

Scandinavian Cardiovascular Journal, Vol. 36, Iss. 4, 2002-08 ,pp. : 225-230

Informa Healthcare

Access to resources Recommend Favorite